Biovica receives € 682,000 in EU funding

[Uppsala, Sweden, June 9, 2015] - The European Commission has selected Biovica as one of the companies to receive support in the Horizon 2020 phase 2 program. Biovicas project entitled “Clinical validation of the DiviTum assay in two high profile clinical studies in Europe” is supported with € 682,000 and is carried out in collaboration with [...]

2017-01-16T12:55:36+01:00 June 9th, 2015 09:00|Regulatory|